@Chrisg79 Both Oestrodose and Oestrogel are estradiol.
IMHO the difference between all Besins' estradiol gels (marketed in different countries as Oestrogel, Oestrodose, Gynokadin and Estrogel) is the manufacturing site.
Different manufacturing sites in different countries mean different raw materials' suppliers and different teams.
Besins should dedicate one manufacturing facility for estradiol gel and the other for testosterone gel, but I suspect the logistics costs would increase.
Since 2012 the manufacturing site in Belgium has been owned by Delpharm, and the gel has been consistent regarding symptom management.
In 2018-2019, Besins had to start production at their own laboratories in France (Montrouge), where they already had been producing Oestrodose for the French market and parallel imports in the UK, due to the higher demand in the UK and elsewhere.
In 2022, the 10 year contract with Delpharm has ended and Besins has purchased the Drogenbos manufacturing site back (Besins was the original owner before 2012).
I suspect Delpharm hasn't given Besins all the details about the gel manufacturing, which they certainly have perfected in a decade, now that they are no longer partners.
Until Besins gets on its feet again, I'm afraid the gel will take some time to acquire the same quality as before, but it will happen eventually.